2022 ACCP Global Conference on Clinical Pharmacy

Poster Presentation

Monday, October 17, 2022
1:00pm – 2:30pm PST

Scientific poster session IV — late-breaking original research

61280 | Changes in G-CSF biosimilar and originator use over time

Pawloski P¹, McDermott C², Vazquez Benitez G¹, DeFor T¹, Mendelsohn A³, Marshall J³, Moyneur E⁴, Bosco J⁵, Bottorff M⁶, Djibo A⁷, Engelhardt E⁸, Jamal-Allial A⁹, Kline A⁷, Li E¹⁰, Li S¹¹, Lin N¹², McBride A¹³, McMahill-Walraven C⁷, Yee G¹⁴, Lockhart C²

¹HealthPartners Institute, Bloomington, MN, USA, ²Biologics and Biosimilars Collective Intelligence Consortium, Alexandria, VA, USA, ³Harvard Pilgrim Healthcare Institute, Boston, MA, USA, ⁴StatLog, Montreal, Canada, ⁵IQVIA, Danbury, CT, USA, ⁶Loyola University Medical Center, Maywood, IL, USA, ⁷CVS Health Clinical Trial Services, Blue Bell, PA, USA, ⁸CVS Health Medical Affairs, Blue Bell, PA, USA, ⁹Carelon Research, Wilmington, DE, USA, ¹⁰Sandoz Inc., Princeton, NJ, USA, ¹¹University of Tennessee Health Science Center, Memphis, TN, USA, ¹²Health Catalyst, Salt Lake City, UT, USA, ¹³Bristol Myers Squibb, New York, NY, USA, ¹⁴University of Nebraska Medical Center, Omaha, NE, USA